Cargando…

APC Loss Prevents Doxorubicin-Induced Cell Death by Increasing Drug Efflux and a Chemoresistant Cell Population in Breast Cancer

Chemoresistance is a major health concern affecting cancer patients. Resistance is multifactorial, with one mechanism being the increased expression of ABC transporters (such as MDR1 and MRP1), which are drug efflux transporters capable of preventing intracellular accumulation of drugs and cell deat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefanski, Casey D., Arnason, Anne, Maloney, Sara, Kotsen, Janna, Powers, Elizabeth, Zhang, Jian-Ting, Prosperi, Jenifer R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145529/ https://www.ncbi.nlm.nih.gov/pubmed/37108784 http://dx.doi.org/10.3390/ijms24087621

Ejemplares similares

APC loss in breast cancer leads to doxorubicin resistance via STAT3 activation
por: VanKlompenberg, Monica K., et al.
Publicado: (2017)

APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
por: Stefanski, Casey D., et al.
Publicado: (2019)

Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
por: Stefanski, Casey D., et al.
Publicado: (2020)

Combating CHK1 resistance in triple negative breast cancer: EGFR inhibition as potential combinational therapy
por: Stefanski, Casey D., et al.
Publicado: (2022)

APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology
por: Odenwald, Matthew A, et al.
Publicado: (2013)

Apc Mutation Enhances PyMT-Induced Mammary Tumorigenesis
por: Prosperi, Jenifer R., et al.
Publicado: (2011)

APC selectively mediates response to chemotherapeutic agents in breast cancer
por: VanKlompenberg, Monica K., et al.
Publicado: (2015)

Erratum to: APC selectively mediates response to chemotherapeutic agents in breast cancer
por: VanKlompenberg, Monica K., et al.
Publicado: (2016)

Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells
por: Astarita, Emily M., et al.
Publicado: (2021)

Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin
por: Joyce, M. Hunter, et al.
Publicado: (2018)

Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin-resistant breast cancer cells
por: Wen, Chunjie, et al.
Publicado: (2019)

Astemizole Sensitizes Adrenocortical Carcinoma Cells to Doxorubicin by Inhibiting Patched Drug Efflux Activity
por: Hasanovic, Anida, et al.
Publicado: (2020)

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
por: Bessone, Federica, et al.
Publicado: (2021)

VLA-4 Induces Chemoresistance of T Cell Acute Lymphoblastic Leukemia Cells via PYK2-Mediated Drug Efflux
por: Berrazouane, Sofiane, et al.
Publicado: (2021)

Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance
por: Giddings, Emily L., et al.
Publicado: (2021)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines
por: Levi, Michela, et al.
Publicado: (2021)

Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux
por: Saha, Jhuma, et al.
Publicado: (2021)

DNA repair and cholesterol-mediated drug efflux induce dose-dependent chemoresistance in nutrient-deprived neuroblastoma cells
por: Chae, Soo Yeon, et al.
Publicado: (2021)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

Epithelial cells as APCs
por: LeBrasseur, Nicole
Publicado: (2008)

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
por: van Oosterwijk, J G, et al.
Publicado: (2013)

Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance
por: Wang, Xiaohong, et al.
Publicado: (2020)

Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin
por: KIM, KWANG-YOUN, et al.
Publicado: (2015)

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells
por: Congras, Annabelle, et al.
Publicado: (2018)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

Effect of Adenomatous Polyposis Coli Loss on Tumorigenic Potential in Pancreatic Ductal Adenocarcinoma
por: Cole, Jennifer M., et al.
Publicado: (2019)

Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells
por: Sheahan, Breanna J, et al.
Publicado: (2022)

Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines
por: Hsiao, Yen-Ling, et al.
Publicado: (2014)

CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma
por: Gerardo-Ramírez, Monserrat, et al.
Publicado: (2022)

Regulated cell death pathways in doxorubicin-induced cardiotoxicity
por: Christidi, Effimia, et al.
Publicado: (2021)

ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
por: Fultang, Norman, et al.
Publicado: (2020)

Different Phenotypic Consequences of Simultaneous Versus Stepwise Apc Loss
por: Fischer, Jared M, et al.
Publicado: (2011)

PKM2 is not required for colon cancer initiated by APC loss
por: Lau, Allison N., et al.
Publicado: (2017)

Soft Tissue Sarcoma Study: Association of Genetic Alterations in the Apoptosis Pathways with Chemoresistance to Doxorubicin
por: Kirilin, Evgeny M., et al.
Publicado: (2022)

Bone Marrow Adipocytes Contribute to Tumor Microenvironment-Driven Chemoresistance via Sequestration of Doxorubicin
por: Kwak, Jun-Goo, et al.
Publicado: (2023)

Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia
por: Qattan, Malak Yahia, et al.
Publicado: (2017)

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
por: Casares, Noelia, et al.
Publicado: (2005)

Cytogenetic Evolution of Human Ovarian Cell Lines Associated with Chemoresistance and Loss of Tumorigenicity
por: Struski, Stéphanie, et al.
Publicado: (2003)

Src/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy
por: Tan, Qixing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u9l03p7229h1ek33gajelnte9q